Cited by 30Mesenchymal stem cell researchTissue Engineering and Regenerative MedicineCardiac Valve Diseases and Treatments

The DOI matches its Crossref record; 6 of the 7 references it cites were found in a registry or an index.

Stem Cell Therapy for Heart Failure: An Unfulfilled Promise?

Open access
Curfman, Gregory·2019·JAMA

Abstract

valve replacement in an unselected population: a report from the STS/ACC Transcatheter Valve Therapy Registry.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2019.2617

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 1

  1. Yau, Effect of intramyocardial injection of mesenchymal precursor cells on successful temporary weaning from left ventricular assist device support among patients with advanced heart failure: a randomized clinical trial, JAMA

Cited by

Sorted by citations

Metadata

Authors
Curfman, G.
Affiliations
Deputy Editor, JAMA
Corresponding author
Curfman, Gregory
Venue
JAMA
Published
2019-03-26
Volume
321
Issue
12
Pages
1186
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2922678205
Cited by
30
References
7
Citations by year
2025: 2 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 11 · 2020: 3 · 2019: 5
FWCI
3.17
Type
journal article
Language
en
Open access
Locations
  • JAMA (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
Keywords
stem cell therapy, heart failure, cell therapy, regenerative medicine
MeSH terms
Heart Failure, Heart-Assist Devices, Humans, Injections, Weaning, Stem Cell Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review